Opera Bioscience enables Biotech partners to produce high purity proteins and antibodies for therapeutic use, while also minimizing development and manufacturing timelines. By harnessing a bacterial system that can fully secrete proteins out of the cell in a single step, Opera Bioscience can ensure the creation of high-purity proteins from the outset. This approach removes the need for costly and time-consuming downstream processing steps, capitalizing instead on highly efficient continuous fermentation processes. The outcome is a protein manufacturing solution that is both cost-effective and scalable, allowing customers to expedite the launch of their biosimilars and therapeutics while keeping production costs at a minimum.
| Website | https://www.operabioscience.com/ |
| Employees | 4 (4 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology |
| Keywords | Protein Production, Antibody Production, Biotechnology, Therapeutic Proteins, Protein Purification, Therapeutic Antibodies, Pharmaceutical Manufacturing, Biopharmaceutical, Antibody Engineering, Drug Development, Recombinant Proteins, Biologics Manufacturing, Biologics Development, Protein Engineering, Pharmaceutical Development, Contract Manufacturing Organization, Cmo, Bioprocessing |
Looking for a particular Opera Bioscience employee's phone or email?
Julie Liang is the Chief Scientific Officer and Co-founder of Opera Bioscience.
4 people are employed at Opera Bioscience.
Opera Bioscience is based in Chicago, Illinois.